🔎 Trials Near Me

Home › Focal Segmental Glomerulosclerosis › New York › New York City

Pag-aaral pangklinika para sa Focal Segmental Glomerulosclerosis sa New York City, NY

Isang pag-aaral para sa Focal Segmental Glomerulosclerosis ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa New York City. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease

Nagre-recruitPhase 2
  • Columbia University Irving Medical Center- Site Number : 8400001, New York
Edad 16 hanggang 75 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT06500702

Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 System

Nagre-recruit
  • Weill Cornell Medicine / NewYork-Presbyterian, New York
Hanggang edad 75 · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT04065438

Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children

Nagre-recruit
  • Weill Cornell Medical Center / NewYork-Presbyterian, New York
Hanggang edad 21 · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT02235857

NEPTUNE Match Study

Nagre-recruit
  • Columbia University Medical Center, New York
Edad 1 hanggang 80 · Lahat ng kasarian · Na-update Hun 10, 2026 · NCT04571658

Nephrotic Syndrome Study Network

Nagre-recruitObservasyonal na pag-aaral
  • New York University Medical Center, New York
  • Bellevue Hospital, New York
  • New York University Veterans Administration, New York
  • at 1 pa
Hanggang edad 80 · Lahat ng kasarian · Na-update Hun 10, 2026 · NCT01209000

AMPK-activation by Metformin in FSGS: AMP-FSGS

Nagre-recruitPhase 1/2
  • Mount Sinai Hospital, New York
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Peb 3, 2026 · NCT06090227

A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB

Nagre-recruitPhase 3
  • Icahn School of Medicine at Mount Sinai, New York
Edad 12 hanggang 80 · Lahat ng kasarian · Na-update Peb 3, 2026 · NCT05183646

Pag-aaral para sa Focal Segmental Glomerulosclerosis sa ibang lungsod

Iba pang pag-aaral sa New York City

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.